YOUNG BAE: Open Payments
NPI 1619931680 · CENTREVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 43 payments from 10 companies in 2025. Trend: 2023 $698 · 2024 $668 · 2025 $886
Food & beverage: $859Education: $27
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $202 |
| Axsome Therapeutics, Inc. | 7 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $139 |
| Lundbeck LLC | 7 | $115 |
| Alkermes, Inc. | 3 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| ABBVIE INC. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: REXULTI, Auvelity, CAPLYTA, ARISTADA, TRINTELLIX, COBENFY, VRAYLAR, FANAPT.
Industry payments across VA — which companies pay providers there.
